| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.36 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.36 | 0.2 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.5 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.3 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.09 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.072 | 0.3 |